Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results. The study abstract is available here.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results. The study abstract is available here.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

FEBRUARY 2, 2022

As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. Alternative tests, such as the LuciX platform from Dutch company Bloonics, are able to provide detailed information about the cannabinoids present in someone’s system, including synthetic cannabinoids. “We

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

The Cannigma

JANUARY 19, 2022

Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. I mean, asking questions was like, how can I function, how can I sleep, how can I not be in pain. EG: Definitely.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). Data collection. This offers a more denotative approach to complement the data.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Healing Advocacy Fund. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51